Skip to main content
Clinical Trials/NCT02152189
NCT02152189CompletedNot Applicable

Screening for Fabry Disease in a Pediatric Population at Risk

University Hospital Heidelberg1 site in 1 country1,422 target enrollmentStarted: May 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
1,422
Locations
1
Primary Endpoint
Prevalence of Fabry disease

Study Overview

Brief Summary

The purpose of this study is to assess the frequency of Fabry disease in children with chronic abdominal pain or chronic pain in the extremities

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
— to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age below 18 years
  • One of the following criteria:
  • Diagnosis or suspicion of a rheumatological disorder with recurrent complaints for more than 6 months
  • Chronic, recurrent abdominal pain for more than 6 months
  • Planned blood sample for routine diagnostics
  • Written informed consent

Exclusion Criteria

  • Patient and/or the patient's parent(s) or legal guardian(s) are unable to understand the nature, scope, and possible consequences of the screening.

Outcomes

Primary Outcomes

Prevalence of Fabry disease

Time Frame: day 1

Secondary Outcomes

  • Prevalence of Fabry disease in predefined sub-populations(day 1)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Markus Ries, MD PhD MHSc FCP

Professor

University Hospital Heidelberg

Study Sites (1)

Loading locations...

Similar Trials